ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis

Breast Cancer trials near Birmingham, AL, USA:

Olaparib In Metastatic Breast Cancer

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Birmingham, Alabama, United States and 19 other locations

This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...

Active, not recruiting
Metastatic Breast Cancer
Breast Carcinoma
Drug: LEE-011
Drug: Fulvestrant

Phase 2

Melissa K Accordino

Birmingham, Alabama, United States and 12 other locations

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Birmingham, Alabama, United States and 10 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Birmingham, Alabama, United States and 9 other locations

and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone previous treatment. Velipari ...

Active, not recruiting
Metastatic Triple Negative Breast Cancer
Drug: Combination of Veliparib + Lapatinib
The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States

This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Trastuzumab

Phase 2

Adrienne G. Waks

Birmingham, Alabama, United States and 16 other locations

In this research study we are studying the effects of the combination of lapatinib plus Herceptin in subjects with breast cancer th...

Active, not recruiting
Breast Cancer
Drug: Lapatinib
Drug: Herceptin

Phase 2

Nancy Lin, MD

Birmingham, Alabama, United States and 8 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

Birmingham, Alabama, United States and 32 other locations

The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers ...

Enrolling
HER2 Positive Breast Carcinoma
Metastatic Breast Cancer
Drug: Trastuzumab
Drug: Niraparib

Phase 1, Phase 2

The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States and 6 other locations

Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...

Enrolling
Breast Cancer
Breast Carcinoma in Situ
Device: Provide a saliva sample for genetic testing
Other: Screening advice based on a basic risk assessment
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

Birmingham, Alabama, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems